GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (WBO:JNJ) » Definitions » Cyclically Adjusted Revenue per Share

Johnson & Johnson (WBO:JNJ) Cyclically Adjusted Revenue per Share : €31.41 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Johnson & Johnson Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Johnson & Johnson's adjusted revenue per share for the three months ended in Dec. 2023 was €8.069. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €31.41 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Johnson & Johnson was 10.80% per year. The lowest was 3.30% per year. And the median was 7.90% per year.

As of today (2024-05-01), Johnson & Johnson's current stock price is €136.14. Johnson & Johnson's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €31.41. Johnson & Johnson's Cyclically Adjusted PS Ratio of today is 4.33.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Johnson & Johnson was 5.90. The lowest was 3.74. And the median was 4.81.


Johnson & Johnson Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Johnson & Johnson's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cyclically Adjusted Revenue per Share Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.03 23.11 27.52 31.27 31.41

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.01 31.43 33.07 31.41 -

Competitive Comparison of Johnson & Johnson's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted PS Ratio falls into.



Johnson & Johnson Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=8.069/129.4194*129.4194
=8.069

Current CPI (Dec. 2023) = 129.4194.

Johnson & Johnson Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 4.556 99.695 5.914
201406 4.992 100.560 6.425
201409 5.003 100.428 6.447
201412 5.209 99.070 6.805
201503 5.681 99.621 7.380
201506 5.636 100.684 7.245
201509 5.428 100.392 6.997
201512 5.839 99.792 7.573
201603 5.599 100.470 7.212
201606 5.887 101.688 7.492
201609 5.700 101.861 7.242
201612 6.206 101.863 7.885
201703 6.031 102.862 7.588
201706 6.116 103.349 7.659
201709 6.022 104.136 7.484
201712 6.223 104.011 7.743
201803 5.940 105.290 7.301
201806 6.552 106.317 7.976
201809 6.393 106.507 7.768
201812 6.576 105.998 8.029
201903 6.565 107.251 7.922
201906 6.761 108.070 8.097
201909 7.050 108.329 8.423
201912 6.986 108.420 8.339
202003 7.011 108.902 8.332
202006 6.109 108.767 7.269
202009 6.705 109.815 7.902
202012 6.918 109.897 8.147
202103 7.015 111.754 8.124
202106 7.242 114.631 8.176
202109 7.416 115.734 8.293
202112 3.235 117.630 3.559
202203 7.977 121.301 8.511
202206 8.517 125.017 8.817
202209 7.589 125.227 7.843
202212 7.094 125.222 7.332
202303 8.871 127.348 9.015
202306 8.974 128.729 9.022
202309 7.846 129.860 7.819
202312 8.069 129.419 8.069

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Johnson & Johnson  (WBO:JNJ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Johnson & Johnson's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=136.14/31.41
=4.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Johnson & Johnson was 5.90. The lowest was 3.74. And the median was 4.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Johnson & Johnson Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (WBO:JNJ) Business Description

Industry
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson (WBO:JNJ) Headlines